Source:Valleywag
So what do these Facebook ads which have MoveOn.org in an uproar actually look like? The ads, despite all the fuss, are cussedly hard to find. Mark Zuckerberg’s hundred-year media revolution seems to be taking about that long to get underway. But Facebook fanboy Dave McClure has found an example in the wild. By buying a T-shirt on Busted Tees, he was able to capture screenshots of the ads MoveOn claims violate Facebook users’ privacy. What do you think?
![]()

Source:Valleywag
Yahoo has launched, in an invitation-only trial, MyM, a “social messaging” service. How many social networks does one company need? Nowhere are Yahoo’s scattershot efforts more evident than in this field. On top of Yahoo Mash, Yahoo 360, Del.icio.us, Flickr, and — if you believe Yahoo president Sue Decker — Yahoo Mail, you can now add MyM to the list.
From what we’ve heard, MyM sounds a lot like Meebo, the website which allows users to access multiple instant-messaging clients at once. MyM will actually hook into Meebo, as well as Friendster, MySpace, LiveJournal, AIM, MSN Messenger, and Yahoo’s own IM software. Internally at Yahoo, MyM’s already been dubbed “awkward,” and some are worried that competitors will block it.
I’d say those concerns are typical of Yahoo these days — suggest something new, and people come up with reasons why you can’t do it, rather than fixes for those problems. Awkward or not, it’s to these Yahoos’ credit that they actually managed to launch something against internal opposition. We’re still skeptical that Yahoo needs yet another social service, but we’re intrigued all the same. Anyone got an invite? Send it in.
![]()

Source:Valleywag
Most passersby don’t notice California Institute for Regenerative Medicine’s austere signage tucked between Borders and Amici’s on King Street, kitty-corner from the ballpark . And the San Francisco-based CIRM has struggled to turn its $3 billion in state funding into an active economic engine for the area. But a breakthrough by researchers at the University of Wisconsin-Madison (birthplace of The Onion) may enable mass production of stem cells from boring old skin cells, rather than by harvesting (read: killing) human embryos. There are still decades of research to be done before stem cells cure diseases. But this bodes well for the stable, science-driven future industry San Francisco leaders have long tried to jumpstart in Mission Bay.
![]()

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
This entry was posted
on Friday, November 23rd, 2007 at 11:27 am and is filed under Top, San Francisco, Biotech, CIRM.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.